CSBR Champions Oncology, Inc.
$4.86▲ +2.97%
Healthcare
Other
Volume 15.2K
Avg Volume (10D) 6.8K
Key Metrics & Fundamentals
Market Cap
$67.64M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.59 - 8.31
% vs 50 MA
-2.19%
% vs 200 MA
-16.03%
RSI-14
48.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.38
Free Cash Flow
-$547,000
Gross Rev
$15.23M
Gross Profit
$7.70M
EBITDA
-$95,000
COGS
$7.53M
Operating Exp
$8.11M
Operating Income
-$409,000
EBIT
-$409,000
Pretax Income
-$415,000
Net Income
-$426,000
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
Capitalize on the Global PDX Models Shift: Benchmark Charles River, Crown Bioscience, Champions Oncology, The Jackson Laboratory and Oncodesign to Secure Precision Oncology ROI
GlobeNewswire · Sep 22, 2026 4:29 AM ET
CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth
Zacks · Sep 15, 2026 11:12 AM ET
Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ...
GuruFocus.com · Sep 14, 2026 9:00 PM ET
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript
Motley Fool · Sep 11, 2026 9:58 AM ET
Champions Oncology, Inc. Q1 2027 Earnings Call Summary
Moby · Sep 11, 2026 8:30 AM ET
Champions Oncology Q1 Earnings Call Highlights
MarketBeat · Sep 10, 2026 5:02 PM ET
Champions Oncology Reports Revenue of $15.2 Million
ACCESS Newswire · Sep 10, 2026 4:00 PM ET
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
ACCESS Newswire · Sep 4, 2026 11:15 AM ET
CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
Zacks · Jul 30, 2026 12:15 PM ET
Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ...
GuruFocus.com · Jul 29, 2026 11:00 PM ET
Financial Overview - Income Statement
Quarterly
Jul 2026
See CSBR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.